Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Helsinn Therapeutics (United States) | Researchclopedia

Back to institutions

Helsinn Therapeutics (United States)

Iselin, New Jerseycompany

122

Works

13,406

Citations

46

h-index

Top Research Topics

Nausea and vomiting management Nutrition and Health in Aging Adipose Tissue and Metabolism

Top Researchers

Charles L. Loprinzi Mayo Clinic in Arizona

838 works47,935 citationsh-index: 107

Recent Research

Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301

G.K. Abou-Alfa,I. Borbath,et al.

20260 citations

Regulation of Appetite and Obesity

Anesthesia and Pain Management

Cutaneous lymphoproliferative disorders research

Chemotherapy-related skin toxicity

Pathogenesis and Treatment of Hiccups

Adipokines, Inflammation, and Metabolic Diseases

Cancer-related molecular mechanisms research

Cancer, Hypoxia, and Metabolism

Pregnancy and Medication Impact

David C. Currow Flinders University

1,251 works38,875 citationsh-index: 86

Axel Grothey West Cancer Center

582 works37,212 citationsh-index: 76

Shaker R. Dakhil Cancer Center of Kansas

439 works36,404 citationsh-index: 79

Amy P. Abernethy Atrium Medical Cente

738 works35,665 citationsh-index: 93

Charles D. Blanke SWOG Cancer Research Network

544 works32,721 citationsh-index: 73

Abstract PS2-02-01: Improved Antiemetic Outcomes with NEPA vs (Fos)aprepitant in Patients with Breast Cancer Receiving Antibody-Drug Conjugates: A 12-Month Real-World Claims Analysis

L. S. Schwartzberg,T. Gillespie,et al.

20260 citations

Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom

Maria Lorenzi,Stephen Ebohon,et al.

20250 citations

A phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR-001 (5-FU-miR-15a) in patients with acute myeloid leukemia

Irini Ktoridou-Valen,Andrea Lenartova,et al.

20250 citations

PROOF 301: Results of an early discontinued randomized phase 3 trial of the oral FGFR inhibitor infigratinib vs. gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma (CCA) with an <i>FGFR2</i> gene fusion/rearrangement.

Ghassan K. Abou‐Alfa,Ivan Borbath,et al.

202415 citations

455P Assessing model-predicted neurokinin-1 (NK1) receptor occupancy (RO) of netupitant to support efficacy over an extended time period

Florian Scotté,Laurent Zelek,et al.

20233 citations